Home Blog Page 1701

AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List

By
Advertorial Desk
-

SINGAPORE, Dec. 15, 2025 /PRNewswire/ — AbbVie ASEAN has been ranked #15 in the inaugural Fortune Best Companies to Work For Southeast Asia 2025 list, in partnership with Great Place To Work®, highlighting workplaces across Singapore, Malaysia, Thailand and the Philippines.

This honor builds on AbbVie’s inclusion in the 2025 Best Workplaces in Asia™ list earlier this year – recognition that spans a wide geographic area assessed by Great Place to Work, covering markets across Asia and the Middle East. It underscores the strength, consistency and quality of our employee experience across roles and genders in these markets. The Fortune list is a highly selective recognition that spotlights companies with truly exceptional workplace cultures.

AbbVie places trust, collaboration and belonging at the center of how teams work together. These behaviors foster an environment where employees feel valued, empowered and inspired to bring their best selves to work, driving engagement and innovation. By prioritizing its people, AbbVie builds stronger teams and delivers greater impact for the patients and communities it serves.

“As a team spanning Singapore, Malaysia, Thailand and the Philippines, being recognized among the best workplaces in Southeast Asia affirms the commitment we make every day to listen, support and enable our people to thrive,” said Rama Vela, General Manager, AbbVie ASEAN — a sub‑region of Asia comprising Singapore, Malaysia, Thailand and the Philippines. “Our people are at the heart of everything we do. This recognition reflects how purpose, inclusion and focus on wellbeing ripple outward – touching not just our teams, but patients and communities across Southeast Asia.”

The Fortune Southeast Asia ranking is based on employee feedback collected through the GPTW Trust Index™ survey — the same survey used for GPTW Certification — and culture audits evaluating trust, leadership effectiveness, innovation and inclusivity. While certification confirms a company meets global standards for a great workplace, the Fortune listing recognizes only the top performers in the region, setting the benchmark for Southeast Asia.

The full list can be found here.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

About Great Place To Work

As the global authority on workplace culture, Great Place To Work brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces List. 

Follow Great Place To Work on LinkedIn, X, and Instagram or visit greatplacetowork.com and sign up for the newsletter to learn more.

CREATIP Wins Gold for Independent Agency of the Year at Campaign 2025 — Leading Digital Marketing Agency in Korea Strengthening Korea & Japan Performance Marketing Across APAC

By
Advertorial Desk
-

SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ — CREATIP, a leading independent digital marketing agency in Korea, announced that it has won Gold in the Independent Agency of the Year category and Silver in the Performance Marketing Agency of the Year category at the 2025 Agency of the Year (AOY) Awards, hosted by Campaign.

CREATIP Wins Gold for Independent Agency of the Year at Campaign 2025
CREATIP Wins Gold for Independent Agency of the Year at Campaign 2025

The AOY Awards evaluate agencies not only on campaign results but also on business growth, strategic excellence, creativity, culture, innovation, regional expansion, and leadership. Among all categories, the Independent Agency of the Year – Gold is regarded as one of the most competitive and rigorous distinctions in the Asia-Pacific marketing industry.

CREATIP was recognized for its strong independent operational capabilities, financial stability, integrated marketing expertise, and digital-first creative approach. In the Performance Marketing category, the agency earned high marks for its data-driven media execution, ROI-focused strategies, AI-powered optimization, and consistently strong results for brands entering or expanding in Korea, Japan, and the broader Asia market.

Since 2020, CREATIP has been recognized annually by the AOY Awards, previously earning distinctions in Influencer Marketing and Social Media Marketing. In 2025, the agency further strengthened its position as a top Korea performance marketing agency, especially after being officially appointed as a NAVER certified agency. With this designation, CREATIP expanded its expertise in NAVER marketing and NAVER ads management, enhancing its data- and AI-driven optimization model to deliver stronger results for brands entering the Korean market.

Following the launch of its Japan office in 2023, CREATIP has continued to expand its footprint across Asia. The agency has confirmed plans to open a new office in Taipei, China in January 2026, offering improved accessibility to key Asian markets and strengthening collaboration with regional partners. With hubs in Korea, Japan, and Taipei, China, CREATIP is building a three-market APAC network to deliver localized creative, influencer strategies, social media content, and performance marketing solutions tailored to each region.

“Our Gold recognition as Independent Agency of the Year confirms that CREATIP has become a truly global marketing agency with strong influence across the Asian market,” said Deukil (Daniel) Kong, Founder & CEO of CREATIP.

“With our expansion from Japan to Taipei, China, we aim to become the most effective and reliable partner for global brands entering the Korean, Japanese, and broader APAC markets.”

Today, CREATIP continues to support global brands looking for Korean market entry, Japan expansion, or APAC-wide digital marketing, offering integrated solutions across influencer marketing, social content, brand strategy, and performance-driven growth.

Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial

By
Advertorial Desk
-

Announcement Highlights:

  • Patient enrolment has been completed in Cynata’s Phase 2 clinical trial of CYP-001 in acute graft versus host disease.
  • The study has enrolled a total of 65 participants in the US, Europe and Australia, each of whom was randomised to receive either steroids plus CYP-001, or steroids plus placebo.
  • Primary evaluation period expected to complete in March 2026, with results in June 2026.
  • CYP-001 has potential to address a major unmet need for the treatment of aGvHD, a life-threatening condition.

MELBOURNE, Australia, Dec. 15, 2025 /PRNewswire/ — Cynata Therapeutics Limited (ASX: “CYP” or “Cynata”), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that patient enrolment has been completed in its Phase 2 clinical trial of CYP-001 in adults with newly diagnosed, high risk acute graft versus host disease (aGvHD).

A total of 65 participants have been enrolled in the trial across numerous clinical centres in the US, Europe and Australia. Each participant was randomised to receive either steroids plus CYP-001, or steroids plus placebo.

The trial involves a 100-day primary evaluation period, which is expected to conclude in March 2026, with results anticipated around June 2026. The primary endpoint is Overall Response Rate at Day 28.

Dr Kilian Kelly, Cynata’s Chief Executive Officer and Managing Director, said: “We are delighted to complete patient enrolment in this trial, which has huge importance to Cynata, as well as to patients afflicted with aGvHD, an extremely debilitating and potentially life-threatening disorder. There remains a significant unmet need for safer and more effective treatments, given that existing treatments often fail to prevent poor outcomes, as well as potentially causing serious safety concerns. We are optimistic that the results of this trial will build on the very encouraging results we saw in Phase 1.”

About aGvHD and CYP-001

Acute graft versus host disease (aGvHD) is a serious and often life-threatening complication of bone marrow transplantation and similar procedures, where the donor’s immune cells (the graft) attack the recipient’s tissues (the host). aGvHD affects up to 50% of patients who receive transplants from other donors. Standard first-line treatment with steroids fails in around half of all aGvHD cases, which are known as “steroid-resistant” or SR–aGvHD cases. Historical two-year survival rates in patients with SR–aGvHD are less than 20%.[1]

Cynata’s Cymerus™ iPSC[2]-derived MSC[3]  product for intravenous use, CYP-001, is designed to modulate the immune system and improve both response rates and survival outcomes in aGvHD. In a successful Phase 1 trial in patients with SR–aGvHD, 87% of patients showed an Overall Response, 53% showed a Complete Response, and 60% survived for at least two years. Importantly, there were no serious adverse events or safety concerns related to CYP-001 treatment. This ground-breaking trial led to two publications in the prestigious journal Nature Medicine.[4],[5] CYP-001 has been granted Orphan Drug Designation[6] by the US FDA for the treatment of aGvHD.

Investors are encouraged to visit the Company’s InvestorHub, where they can view a video of Dr Kelly summarising this announcement.

-ENDS-

Authorised for release by Dr Kilian Kelly, CEO & Managing Director 

About Cynata Therapeutics (ASX: CYP)

Cynata Therapeutics Limited (ASX: CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on Cymerus™, a proprietary therapeutic stem cell platform technology. Cymerus™ overcomes the challenges and limitations of conventional MSC production by using induced pluripotent stem cells (iPSCs) to achieve economic manufacture of cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale without the necessity to obtain tissue from multiple donors on an ongoing basis, and without the complexity and product inconsistency resulting from conventional methods.

Cynata has demonstrated positive safety and efficacy data for its Cymerus™ product candidates CYP-001 and CYP–006TK in Phase 1 clinical trials in steroid-resistant acute graft versus host disease (GvHD) and diabetic foot ulcers (DFU), respectively. Further clinical trials are now ongoing: a Phase 2 trial of CYP-001 in GvHD under a cleared US FDA IND; a Phase 1/2 trial of CYP–001 in patients undergoing kidney transplantation; and a Phase 3 trial of CYP-004 in osteoarthritis. In addition, Cynata has demonstrated utility of its Cymerus™ technology in preclinical models of numerous other diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome (ARDS) and cytokine release syndrome.

Cynata Therapeutics encourages all current investors to go paperless by registering their details with the designated registry service provider, Automic Group.  

[1] Westin JR et al. Adv Hematol. 2011;2011:601953

[2] iPSC = induced pluripotent stem cell.

[3] MSC = mesenchymal stem (or stromal) cell.

[4] Bloor AJC, et al. Nat Med. 2020;26:1720–1725

[5] Kelly K, et al. Nat Med. 2024;30:1556–1558

[6] Orphan Drug Designation qualifies Cynata for incentives including extended marketing exclusivity, tax credits and fee waivers.

Five Talent Shifts Redefining Hiring in Hong Kong: PERSOL Unveils 2025 Workforce Insights

By
Advertorial Desk
-

PERSOL’s latest Industry Insight Report reveals how digitalisation, sustainability and shifting worker expectations are transforming recruitment and retention across Asia Pacific.


HONG KONG SAR – Media OutReach Newswire – 15 December 2025 – PERSOL has released its Industry Insight Report 2025, revealing an urgent need for employers across Asia Pacific to adapt to a fast-changing talent landscape. With hybrid digital and ESG-related skills in short supply, the study finds that employee expectations for flexibility, purpose and growth now outweigh pay, reshaping talent attraction and retention across the region.

2025 talent trends and hiring priorities
2025 talent trends and hiring priorities

In Hong Kong, hiring remains selective, with steady demand for digital sales talent, bilingual professionals and frontline leaders. Employers are also facing rising wage pressure and waning youth interest in frontline roles, prompting businesses to rethink how they attract and engage talent. To fill critical service and customer-facing roles, companies are increasingly widening their talent search across the broader region to address persistent shortages.

Based on findings from 12 markets and four core sectors – Manufacturing, Consumer, Professional Services and Supply Chain – the report offers a regional view of how work and workforce priorities are evolving.

APAC’s Workforce in Flux

PERSOL’s Industry Insights Report 2025 finds that automation, sustainability regulation and demographic change are reshaping labour markets across the region.

Employers continue to face widespread skills shortages, with demand for digital, analytical and hybrid capabilities outpacing supply in most major markets. ESG awareness and compliance literacy are also becoming essential hiring criteria as organisations respond to growing sustainability expectations.

The report highlights that Generation Z and millennial professionals are reshaping what they value at work, prioritising flexibility, purpose and development opportunities over pay alone. According to the International Labour Organization (ILO), Asia and the Pacific remains the world’s fastest-growing employment region, underscoring the need for businesses to evolve workforce strategies in line with these shifting expectations.[1]

Elvin Tan, Regional Director and Head of Operations APAC said, “The region’s talent economy is at a crossroads. Workforce gaps are no longer just about headcount. They are about adaptability. Employers who balance technology investment with cultural intelligence and purpose-led hiring will emerge stronger in the next cycle.”

The Five Talent Shifts Defining the Future of Work

The report identifies five interconnected shifts reshaping how employers hire, engage and compete for talent across Asia Pacific.

  • At the heart of this transformation is the rise of hybrid skills, where digital fluency and human capability increasingly go hand in hand. These capabilities are especially important in digital sales and customer-facing roles, where employers look for talent who can combine technical proficiency with strong communication skills.
  • Closely linked to this is the growing importance of sustainability and compliance literacy. As ESG expectations become more deeply embedded in business strategy, roles once limited to sustainability teams are now expanding across finance, operations and supply chain functions.
  • The study also points to a major shift in the employer–employee dynamic, with candidates behaving more like consumers. Jobseekers expect transparency, mobile-first communication and a sense of purpose from the hiring process itself. This trend is evident locally, where bilingual candidates increasingly evaluate organisations on culture, stability and clear growth pathways.
  • These evolving expectations are most visible among younger professionals, particularly Gen Z and millennials, who prioritise flexibility, belonging and personal growth. For many, meaningful work and supportive leadership now matter more than salary alone.
  • The report also highlights a growing need for stronger collaboration between businesses, educators and government to keep skills development aligned with evolving workforce demands. In Hong Kong, this coordinated approach is becoming increasingly important as industries adapt to rapid digitalisation, rising service expectations and ongoing talent shortages.

Zen Loh, Managing Director & Strategic Business Group Head said, “This report reflects PERSOL’s commitment to equipping our clients with data-driven insights that translate into real workforce strategies. We’re helping businesses and jobseekers prepare for what’s next by understanding the skills, mindsets and motivations shaping the future of work.”

Empowering Organisations for What’s Next

PERSOL believes that insight is only powerful when it drives action. Across Asia Pacific, the company works alongside organisations to turn workforce intelligence into real progress, helping them attract, develop and retain the people who will shape the next generation of work.

Download the PERSOL Industry Insight Report 2025 at www.persolapac.com/industry-insights-2025 to explore the trends transforming how Asia Pacific works, hires and grows.

[1] International Labour Organization (ILO), World Employment and Social Outlook 2025: Asia and the Pacific – May Update. Published May 2025.

Hashtag: #PERSOL

The issuer is solely responsible for the content of this announcement.

About PERSOL in APAC

PERSOL is Asia-Pacific’s leading Staffing and HR solutions partner, operating across 13 markets with deep local insight and regional scale. With more than 140 offices and decades of experience, we deliver integrated workforce solutions that are tailored, tech-enabled, and designed for the dynamic world of work.

We combine human expertise with smart technology to help organisations solve workforce challenges, unlock potential, and stay ahead of change. From recruitment and talent management to workforce strategy and advisory, our collaborative approach puts your goals at the centre.

In 2025, we came together under the PERSOL name – reflecting our bold vision for the future of work and our Group’s Vision: ‘Work and Smile’. Whether you’re building teams, growing careers, or transforming how work gets done, we’re here.

THE HONEST FARMER Co Ltd Targets U.S. Health Snack Market with New ‘WELLINUS’ Black Barley Brown Rice Chips

By
Advertorial Desk
-

SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ — THE HONEST FARMER Co Ltd, a food manufacturer based in Yeongcheon, Gyeongbuk, announced its entry into the U.S. health snack market with the launch of its export-exclusive brand WELLINUS. The company plans to introduce its Black Barley Brown Rice Chips—made only with Korean-grown black barley and brown rice—starting with its participation in the 2025 LA Korean Festival held at Seoul International Park in Los Angeles.

In the U.S., health-focused consumption continues to grow, particularly within the processed foods category. Demand is increasing for low-calorie, grain-based snacks, as well as gluten-free and additive-free products. THE HONEST FARMER’s chips contain 0g trans fat, 0g sodium, and 0g sugar, with each piece delivering approximately 29–32 kcal, positioning it as an attractive option for clean-label-minded consumers.

The company is currently preparing export agreements with U.S. distributors specializing in health foods, online snack platforms, and organic-focused retailers. Packaging and labeling will also be adapted to meet U.S. regulatory requirements. The brand name WELLINUS reflects the meaning “well in us,” emphasizing health, trust, and a commitment to clean, transparent food values.

A company spokesperson stated, “Our additive-free grain chips made from Korean black barley and brown rice align perfectly with the clean label trend among U.S. consumers. We plan to position the product not just as a snack, but as a health-conscious option that supports long-term brand growth in the American market.”

THE HONEST FARMER expects its U.S. expansion to serve as more than a simple export initiative—marking a strategic step toward becoming a global health snack brand and a key opportunity to demonstrate the competitiveness of K-snacks in North America.

 

Chris Colahan to Join Chubb as Head of Commercial Property & Casualty, Asia Pacific

By
Advertorial Desk
-

SINGAPORE – Media OutReach Newswire – 15 December 2025 – Chubb announced today the appointment of Chris Colahan as Head of Commercial Property & Casualty, Asia Pacific, effective 9 February 2026. In this role, Colahan will have overall operating responsibility for Chubb’s Commercial Property & Casualty portfolio throughout the Asia Pacific region.

Colahan will report to Marcos Gunn, Regional President of Chubb Overseas General, Asia Pacific, and Brian Church, Division President, Property & Casualty, Chubb Overseas General. He will also join the company’s Asia Pacific Executive Committee.

On announcing Colahan’s appointment, Gunn said, “We are delighted that Chris is joining the Chubb team. He is a proven industry leader, with an extensive and deep understanding of the region, which will be invaluable as we continue to build our business in Asia Pacific. Chris is widely recognised for his commitment to excellence, and we are confident that under his leadership, our Property & Casualty business will continue to deliver outstanding results for our partners and clients.”

Colahan joins Chubb from AIG where he was the Regional President for Asia Pacific. Prior to this he held senior roles with Berkshire Hathaway Specialty Insurance in London and Australia, and at RSA Insurance across the region.

Colahan holds a Bachelor of Laws from Bond University.

Hashtag: #Chubb

The issuer is solely responsible for the content of this announcement.

About Chubb

Chubb is a world leader in insurance. With operations in 54 countries and territories, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. The company is defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (NYSE: CB) and is a component of the S&P 500 index. Chubb employs approximately 43,000 people worldwide. Additional information can be found at:

Avnet and AMD Showcase Scalable AI Solutions to Accelerate Australia’s Tech Leadership

By
Advertorial Desk
-

SYDNEY, Dec. 15, 2025 /PRNewswire/ — Avnet and AMD have wrapped up the inaugural ‘AMD on Wheels’ national roadshow, bringing cutting-edge AI and high-performance computing solutions to innovation hubs across Australia. The initiative reaffirmed the partners as definitive industry leaders by demonstrating the critical intersection of AI, sustainability, and commercial acceleration.

Demonstrating a commitment to the environment that parallels their focus on energy-efficient computing, the roadshow team travelled over 4000 KM through Sydney, Canberra, Melbourne and Adelaide with pure Electric Vehicles, the ZEEKR 7X and ZEEKR 009.

The roadshow shifted focus from individual components to complete, deployable AI and high-performance computing solutions. By showcasing this end-to-end capability, Avnet and AMD reinforced their commitment to providing secure, adaptable, and energy-efficient infrastructure—capabilities that are critical to enabling Australia to capture the broader AI opportunity that analysts estimate could, in an ambitious scenario, add up to around AU$142 billion a year to Australia’s GDP by 2030. (Source: Australia’s AI Opportunity report, 2025)

“Avnet and AMD are strategically invested in advancing Australia’s capability in Responsible AI and next-generation computing,” said Tan Aik Hoon, Avnet’s Regional President for South Asia, Korea and Avnet United. “This roadshow proved why Avnet is the trusted partner for turning bold ideas into real-world success. Beyond distribution, Avnet helps innovators transform advanced AMD hardware into scalable, sustainable solutions that strengthen Australia’s competitive edge.”

The tour highlighted that Australia’s next leap in innovation requires strong cross-sector collaboration. The ‘Industry Collaboration for AI at Scale’ panel, featuring leading industry experts and key figures from academia, addressed the critical challenge of scaling projects from pilot phase to full deployment. The ecosystem’s resilience and capability were demonstrated by local success stories spanning defense, quantum, and space technology:

  • Advanced Navigation – Delivering Space-Ready Precision Systems
    Advanced Navigation leveraged the “Avnet to the Moon” initiative to support its Laser Measurement Unit for Navigational Aid (LUNA), successfully delivering mission-critical components for operation in space and extreme environments. Through technology and supply support from Avnet and AMD, LUNA shows how local innovation can achieve space-grade reliability and strengthen Australia’s position in the global space supply chain.
  • Quantum Brilliance – Scaling Quantum from Lab to Market
    Quantum Brilliance advanced toward commercial deployment by transitioning to the AVNET+ AMD based ADRS1000 SOM. Despite global shortages, Avnet secured timely delivery, enabling QB to move from prototypes to production. The collaboration highlights how reliable supply chains can accelerate quantum commercialization and maintain Australia’s competitive edge in frontier technologies.
  • Liquid Instruments – Bringing Agentic AI to Test & Measurement
    Liquid Instruments is advancing test and measurement with Generative Instrumentation and agentic AI on its Moku platform, powered by AMD FPGAs. Launching with Moku:Delta in 2026, these natural-language-driven tools let engineers create and configure instruments in minutes. With support from Avnet and AMD, Moku is enabling faster, smarter experimentation across Australia’s research and manufacturing sectors.
  • Silentium Defence – Advancing Passive Radar for Defence, Space Surveillance and Critical Infrastructure
    Silentium Defence SWaP-optimized passive radar systems, built on AMD technology, demonstrate how long-term collaboration accelerates defence-grade sensing. With Avnet’s global supply chain and engineering support, Silentium Defence has moved from early prototypes to production-ready platforms, giving global customers stronger capability in next-generation radar technology.

“The next wave of AI innovation in Australia must be built on a foundation of Responsibility and Efficiency,” said Steven Fong, Corporate Vice President, Asia Pacific & Japan Embedded Sales at AMD. “We are committed to delivering the energy-efficient computing power that fuels this responsible acceleration, helping partners secure their competitive edge while aligning with national sustainability goals.”

Avnet and AMD see the roadshow not as an endpoint, but as a blueprint for the future of Australian technology. By strengthening the pipeline between world-class research and commercial deployment, the partners are actively creating the foundational infrastructure—from the most advanced processors to the most secure supply chain—that will guarantee Australia’s resilience and long-term technological leadership in the global AI landscape. 

About Avnet

As a leading global technology distributor and solutions provider, Avnet has served customers’ evolving needs for more than a century. Through regional and specialised businesses around the world, we support customers and suppliers at every stage of the product lifecycle.  We help companies adapt to change and accelerate the design and supply stages of product development. With a unique viewpoint from the center of the technology value chain, Avnet is a trusted partner that solves complex design and supply chain issues so customers can realise revenue faster.  Learn more about Avnet at www.avnet.com.

Avnet and AMD are registered trademarks of Avnet, Inc. and Advanced Micro Devices, Inc. Other names and brands may be claimed as the property of others.

CONTACT: 

Seraphina Wee
Corporate Communications and PR lead
Avnet Asia Pte Ltd
Seraphina.Wee@AVNET.COM 

ZAKSIMLAB Set to Launch Cabbage-Based Electrolyte Drink, Signaling New Innovation in the Functional Beverage Market

By
Advertorial Desk
-

SEOUL, South Korea, Dec. 14, 2025 /PRNewswire/ — ZAKSIMLAB is gearing up to introduce a new electrolyte drink made with cabbage as its primary ingredient, signaling another bold move in Korea’s rapidly evolving functional beverage market. Cabbage-fermented electrolytes are rarely seen in the domestic beverage industry, drawing strong consumer interest for their dual focus on gut health and hydration.

ZAKSIMLAB has continued to differentiate itself by combining fermentation techniques with natural, clean-label ingredients to create wellness-focused beverages. Building on this foundation, the company plans to expand its functional lineup through seasonal product launches, strengthen collaborations with cafés and F&B partners, and accelerate overseas test sales and export initiatives as it positions itself as a global wellness brand.

A ZAKSIMLAB official commented, “A cabbage-based electrolyte drink is a rare and innovative addition to the electrolyte beverage category,” adding, “This launch will further solidify our identity as a wellness brand rooted in advanced fermentation technology.”

 

1...1,7001,7011,702...6,661Page 1,701 of 6,661